Home > Insider Trading > Filing (0001179110-17-000240)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1235007	Endocyte Inc	ECYT	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1509415	P Christopher Leamon	3000 Kent Ave, Suite A1-100 West Lafayette IN 47906	Vice President Of Research	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2016-12-30	26,178	$2.10	90,227	No	4	M	Direct
Common Stock	Disposition	2016-12-30	23,244	$2.55	66,983	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (right to buy)	Disposition	2016-12-30	26,178	$0.00	26,178	$2.10

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0		2017-02-01	No	4	M	Direct

Footnotes

Includes 1,051 and 1,450 shares acquired under the Endocyte, Inc. 2010 Employee Stock Purchase Plan on June 15, 2016 and December 15, 2016, respectively.
Represents the sale of 23,244 shares in multiple transactions, ranging in price from $2.52 to $2.61 per share, resulting in a weighted average sale price per share of $2.55. The reporting person will provide, upon request by the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range. Shares were sold to cover the option exercise price and to satisfy the tax withholding obligation.
The option is fully vested and immediately exercisable.